Education
About Us
Working with TipRanks
Follow Us
Intervacc AB (SE:IVACC)
:IVACC
IVACC Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.73 - kr3.09
Previous CloseN/A
Volume791.15K
Average Volume (3M)628.37K
Market Cap
€348.31M
Enterprise Valuekr116.02M
Total Cash (Recent Filing)€202.05M
Total Debt (Recent Filing)€88.00K
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Nov 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding340,813,200
10 Day Avg. Volume403,441
30 Day Avg. Volume628,369
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.54
Price to Sales (P/S)7.49
P/FCF Ratio-1.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.00Price Target Upside-2.40% Downside
Rating ConsensusHold
Number of Analyst Covering0
IVACC FAQ
What was Intervacc AB’s price range in the past 12 months?
Intervacc AB lowest stock price was kr0.73 and its highest was kr3.09 in the past 12 months.
What is Intervacc AB’s market cap?
Intervacc AB’s market cap is €348.31M.
When is Intervacc AB’s upcoming earnings report date?
Intervacc AB’s upcoming earnings report date is Nov 19, 2025 which is in 50 days.
How were Intervacc AB’s earnings last quarter?
Intervacc AB released its earnings results on Aug 29, 2025. The company reported -kr0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.05.
Is Intervacc AB overvalued?
According to Wall Street analysts Intervacc AB’s price is currently Overvalued.
Does Intervacc AB pay dividends?
Intervacc AB does not currently pay dividends.
What is Intervacc AB’s EPS estimate?
Intervacc AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intervacc AB have?
Intervacc AB has 340,813,200 shares outstanding.
What happened to Intervacc AB’s price movement after its last earnings report?
Intervacc AB reported an EPS of -kr0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 12.811%.
Which hedge fund is a major shareholder of Intervacc AB?
Currently, no hedge funds are holding shares in SE:IVACC
Company Description
Intervacc AB
Intervacc AB (IVACC) is a biotechnology company based in Sweden, specializing in the development, production, and commercialization of innovative veterinary vaccines. The company focuses on advancing vaccines that target bacterial infections in animals, primarily within the livestock and equine sectors. Intervacc's core products are developed using proprietary technology platforms that enhance the efficacy and safety of animal vaccines.
Technical Analysis
Xbrane Biopharma AB
―
Elicera Therapeutics AB
―
Ascelia Pharma AB
―
IRLAB Therapeutics AB Class A
―
Immunicum AB
―